Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Sponsor and Collaborators
Cancer Research Campaign Clinical Trials Centre

Principal Investigator
John Kelly, MD
University College London Hospitals

ClinicalTrials.gov Identifier
NCT01094964